The exploratory study for the efficacy and safety of rikkunshito on anorexia in the patients who underwent laparoscopic assisted pylorus preserving gastrectomy
Not Applicable
- Conditions
- Gastric cancer patient who underwent LAPPG
- Registration Number
- JPRN-UMIN000002295
- Lead Sponsor
- The Cancer Institute Hospital of JFCR Gastroenterological Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with multiple cancer 2)Patients who have nutritional disorder before surgery 3)Patients whose main organ function is not working 4)Patients who had administration of other Kampo medicine 1 month prior to the administration of test drug 5)Patients with severe cardiac failure, acute inflammatory disease or other severe complications 6)Patients who are intolerant to oral administration 7) Patients who are pregnant, considering pregnancy or lactation 8)Patients with gastrointestinal bleeding, mechanical ileus, gastrointestinal perforation 9)Patients who has history of hypersensitivity toward Kampo medicine 10)Patients considered inappropriate by the study investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of anorexia and rate of body weight loss after LAPPG
- Secondary Outcome Measures
Name Time Method Abdominal pain, dyspepsia and other gastrointestinal symptoms. Nutritional factor. Safety of rikkunshito